BackgroundThe butanol fractionated root extract of Asparagus africanus Lam., a traditional herb widely used to treat various ailments were analyzed for the presence of potential toxicity after single (acute) and repeated (subchronic) dose oral administration in adult swiss albino mice using gavages.MethodsFor the acute study, butanol fractionated extract of the plant was administered in single doses of 1000, 3000 and 5000 mg/kg body weight. In the sub-chronic dose study, the extract was administered at doses of 300 and 600 mg/kg body weight/day for 42 days. Selected hematological and biochemical parameters of the blood followed by histopathological analysis were investigated after 42 days of daily administrations. The results were expressed as M ± SE, and differences at P < 0.05 was considered significant. One way analysis of variance (ANOVA) and least significant difference tests were employed to check the significant differences between the various parameters of the experimental groups.ResultsIn the acute study, the extract did not caused dose-dependent general behavioral adverse effects, body weight change and mortality. The single dose toxicity studies therefore showed that the butanol fraction of the extract has high safety profile when given orally. After 42 days of daily dosing, in the sub-chronic study, no clinically significant changes were observed for hematological and biochemical parameters. Except an occasional small number of focal mononuclear lymphocytic cells infiltrations around the central and portal triad of the liver of a few mice, the histopathological parameters do not show significant change.ConclusionIt is concluded that, the butanol fractionated extract from A. africanus at the given dose does not show significant toxicity. The presence of focal inflammation on the liver of a few mice may be associated to the presence of flavonoid glycoside in the butanol fractionated extract.
Construction contracts are susceptible to disputes as they regulate very complex multi-party relationships. Previous studies not only fail to aptly outline the distinction between "conflict" and "dispute", but also fail to adequately study the causes of construction disputes in-light of project delivery systems. The present research aims at assessing the causes and settlement mechanisms of construction disputes in Design-Bid-Build (DBB) and Design-Build (DB) delivery systems with a view to add evidence to the existing knowledge. Accordingly, four most relevant causes of construction disputes identified from previous works of literature were incorporated in a questionnaire survey to determine their frequency of occurrence in the two delivery systems. The Relative Important Index (RII) of the four direct causes of construction disputes computed by SPSS software revealed that, in DBB contracts, the frequency of occurrence of disputable claims (unsettled claims for money/extension of time) has RII = 0.794969/0.777358, project delay has RII = 0.708176, and poor quality of work has RII = 0.469182. In DB contracts, the frequency of occurrence of disputable claims has RII = 0.533333/0.515723, project delay has RII = 0.495597, and poor quality of work has RII = 0.465409. The RII values proved that, DBB projects are significantly prone to disputes than DB projects. Furthermore, qualitative data obtained from road and building project reports exposed that DBB projects are exceedingly prone to disputes because they are frequently vulnerable to an increase in the volume of work due to frequent change orders and design deficiencies. The research further found out that, despite a clear proscription in the laws of the land, there is a routine out of court settlement of public construction disputes in Ethiopia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.